Skip to main content
Dr. Farzana Alam, in a blue shirt and tan blazer

Farzana Alam, PhD

Academic Information

Departments College of Pharmacy , Research Assistant Professor - Pharmacology & Toxicology

Academic Office Information

farzana.alam@pharm.utah.edu

Research Interests

  • Educational research in active learning
  • Cancer research

Mission & Vision

Dr. Farzana Alam is dedicated to advancing translational cancer research and transforming pharmacy education through student-centered, evidence-based active learning. Her mission is to deepen scientific understanding of high-grade serous ovarian cancer metastasis and to pioneer novel therapeutic strategies using engineered extracellular vesicles. Alongside her commitment to scientific innovation, Dr. Alam champions pedagogical excellence by developing inclusive and engaging learning environments that empower students to become critical thinkers and life-long learners. As a program director, her goal also is to strengthening the MS in Pharmacology & Toxicology (PHTX) program as a leading professional development pathway in the state of Utah and beyond.

Research Focus

Dr. Alam’s research program is centered on uncovering the molecular and cellular mechanisms that drive high-grade serous ovarian cancer metastasis, with particular emphasis on tumor dissemination, therapeutic resistance, and metastatic niche formation. Her work integrates mechanistic cancer biology with advanced bioengineering approaches to address critical unmet needs in ovarian cancer treatment.

A major focus of her laboratory is the engineering of extracellular vesicles (EVs) as targeted drug delivery platforms for high-grade serous ovarian cancer. By leveraging the natural biological properties of EVs, her research aims to improve drug specificity, enhance therapeutic efficacy, and overcome limitations associated with conventional chemotherapy. This work builds on her broader interest in nanomedicine, tumor microenvironment interactions, and translational oncology.
 


Dr. Alam actively pursues extramural funding to support these efforts and to expand collaborative, interdisciplinary research that bridges pharmacology, cancer biology, and drug delivery science. Through her research program, she is committed to mentoring graduate, undergraduate, and postdoctoral trainees in rigorous, hypothesis-driven and translational research.

Selected Awards & Funding

Breast Cancer and Gynecological Cancer Pilot Award, Huntsman Cancer Institute (2026–2027)
“Deciphering the Role of Exosome-Expressing Doppel in Malignant Ascites of Ovarian Cancer”

Teaching Philosophy 

Dr. Alam is passionate about student-centered teaching that prioritizes active learning. She believes that learning is most effective when students are actively engaged, connected to real-world problems, and empowered to explore, reflect, and apply knowledge. Her teaching approach blends evidence-based instructional strategies, inclusive pedagogies, and thoughtful integration of emerging technologies—such as AI tools—to enhance student participation and deepen conceptual understanding in both undergraduate and graduate courses. Dr. Alam’s commitment to educational innovation stems from her research in active learning, where she seeks to improve outcomes by tailoring instruction to diverse learner needs.

Graduate Program Leadership & Professional Development 

In her role as Program Director for the MS in Pharmacology & Toxicology (PHTX), Dr. Alam is committed to strengthening the program’s academic rigor, professional development opportunities, and career outcomes. One of her key goals is to position the PHTX master’s program as one of the most sought-after professional graduate programs in the state, recognized for excellence in training, mentorship, and workforce readiness.

Her efforts focus on:

  • Enhancing career-focused curricula aligned with industry, research, and healthcare pathways
  • Integrating professional skills training, mentorship, and experiential learning
  • Expanding student support, visibility, and placement outcomes
  • Building a program identity that attracts diverse, high-caliber students

Through these initiatives, Dr. Alam aims to ensure that PHTX graduates are not only scientifically strong but also professionally competitive and confident in their career trajectories.

Professional Goals 

  • Advance ovarian cancer metastasis research through mechanistic and translational studies
  • Develop engineered extracellular vesicles as next-generation drug delivery platforms for high-grade serous ovarian cancer
  • Sustain a competitive, grant-funded research program through federal and foundation support
  • Innovate in active learning pedagogy to improve student engagement and outcomes
  • Elevate the PHTX MS program as a premier professional and academic training program in Utah

Dr. Alam’s integrated mission—combining high-impact research with transformative teaching—reflects her commitment to excellence in science, education, and mentorship.
 

RELATED LINKS

U of U Faculty Profile

College of Pharmacy

Education History

Pharm D 2006, University of Development Alternative, Dhaka, Bangladesh
B Pharm
Professional Other 2010, Seoul National University, Seoul, South Korea
MSc in Pharmaceutical Sciences
2015, Seoul National University, Seoul, South Korea
PhD in Molecular Medicine and biopharmaceutical Sciences
Doctoral Training 2016-2018 Texas Tech University Health Sciences Center Amarillo, Tx
Post-doctoral fellow

Selected Publications

Journal Article

  1. Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption. H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan International journal of pharmaceutics 544 (1), 285-296

  2. Oral drug delivery systems using chemical conjugates or physical complexes. TA Al-Hilal, F Alam, Y Byun; Advanced drug delivery reviews 65 (6), 845-864

  3. Oligomeric bile acid-mediated oral delivery of low molecular weight heparin. Taslim A Al-Hilal, Jooho Park, Farzana Alam, Seung Woo Chung, Jin Woo Park, Kwangmeyung Kim, Ick Chan Kwon, In-San Kim, Sang Yoon Kim, Youngro Byun; Journal of controlled release 175, 17-24

    More Selected Publications